TY - JOUR
KW - familial hypercholesterolaemia
KW - Hypercholesterolaemia
KW - lipid-lowering therapy
KW - Prevalence
KW - Primary health care
AU - A. Durand
AU - C. Morgan
AU - S. Tinsley
AU - E. Hughes
AU - T. McCormack
AU - C. Bitchell
AU - R. Lahoz
AD - Novartis UK Ltd, London, UK.
Pharmatelligence, Cardiff, UK.
Sandwell and West Birmingham Hospitals NHS Trust and University of Aston Medical School, Birmingham, UK.
Institute of Clinical and Applied Health Research, Hull York Medical School, Hull, UK.
Novartis AG, Basel, Switzerland.
AN - 38325890
BT - Br J Gen Pract
C2 - PMC10877619
DO - 10.3399/bjgp.2023.0010
DP - NLM
ET - 2024/02/08
LA - eng
M1 - 740
N1 - 1478-5242
Durand, Adeline
Orcid: 0000-0001-9581-1102
Morgan, Christopher Ll
Orcid: 0000-0001-8796-7406
Tinsley, Steven
Hughes, Elizabeth
McCormack, Terry
Orcid: 0000-0002-9688-6031
Bitchell, Charlotte L
Orcid: 0000-0002-0421-7392
Lahoz, Raquel
Orcid: 0000-0002-7968-7073
Journal Article
England
Br J Gen Pract. 2024 Feb 7;74(740):e174-82. doi: 10.3399/BJGP.2023.0010.
PY - 2024
SN - 0960-1643 (Print)0960-1643
SP - e174
EP - 82
T2 - Br J Gen Pract
TI - Familial hypercholesterolaemia in UK primary care: a Clinical Practice Research Datalink study of an under-recognised condition
VL - 74
ER -